AI-powered screening for cardiovascular health

QuanCardio platform utilizes AI to provide real-time analysis of 25+ biomarkers for rapid and precise vascular screening at point of care.

Changing the future of vascular disease

of cardiovascular diseases are preventable

The current US medical system often only performs check-ups when patients are already symptomatic, leading to late-stage discoveries. QuanBio's device and SaaS solution allow practitioners to quickly and affordably examine patients, providing extensive data in minutes.

Non-invasive sensors

PPG device rapidly measuring arterial stiffness, a non-invasive approach to cardiovascular health.

AI screening

Leveraging advanced machine learning algorithms, validated through extensive clinical data.

Improving access

Our platform provides healthcare practitioners with detailed insights for personalized patient care.

Where technology meets cardiovascular health

QuanCardio platform eliminates uncertainty in treatment decisions

Real-Time Results: Measured in minutes

Ease of Use: Non-invasive technology

AI Precision: Validated extensively

No guesswork, Just science!

Applying vascular data science and machine learning to raw physiological waveforms

Systematically built upon years of scientific R&D and clinical validation

Using large data sets to build machine and deep learning models

Our MissionPowering affordable vascular care for all

Redefining the landscape of cardiovascular testing with pioneering technology. Addressing the unmet need for in-time detection of vascular disease to prevent severe outcomes and improve patient care.

Revolutionize cardiovascular health with QuanBio

Discover AI-powered, non-invasive vascular screening for personalized patient care.

Copyright © 2024 Quantum BioTek - All Rights Reserved.

Follow us at @guantumbiotek

Note: Quanbio's cardio vascular platform is still under development and not yet approved in the United States.